DANAHER CORP /DE/ (DHR) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$212.62

From 52W high−12.51%

Volume8.78M

Market cap$148.87B

P/E (TTM)37.5x

P/S (TTM)5.9x

Div yield0.68%

Key dataSep 18, 2026

Open

$212.62

From 52W high

−12.51%

Volume

8.78M

Market cap

$148.87B

ValuationView details →

P/E (Fwd)

23.9x

EV/EBITDA

23.9x

P/E (TTM)

37.5x

RSI (14)

56.3

MomentumView details →

1D Return

−0.34%

YTD Return

−7.59%

SummaryUpdated Jun 1, 2026

Danaher Corporation (NYSE:DHR) is a diversified life sciences and diagnostics company founded in 1969 and headquartered in Washington, D.C. Originally established as Diversified Mortgage Investors, Inc., the company underwent a significant transformation and changed its name to Danaher Corporation in 1984. Over the decades, Danaher has evolved from a diversified industrial conglomerate into a focused life sciences powerhouse through strategic acquisitions and divestitures. The company went public in 1978 and has since built a portfolio of leading brands serving the biotechnology, life sciences research, and clinical diagnostics markets worldwide.

Ask drillr about DANAHER CORP /DE/ →

ValuationView details →

P/E (Fwd)

23.9x

P/E (TTM)

37.5x

EV/EBITDA

23.9x

EV/Sales

6.8x

P/S (TTM)

5.9x

P/B (TTM)

2.8x

ProfitabilityView details →

Gross Margin

58.51%

Net Margin

15.95%

EBITDA Margin

28.48%

ROE (TTM)

7.61%

ROA (TTM)

4.33%

Asset Turnover

0.29x

GrowthView details →

Revenue YoY

+4.56%

EPS YoY

+19.45%

FCF YoY

+12.42%

Revenue CAGR 3Y

−2.67%

EPS CAGR 3Y

−19.72%

EBITDA YoY

+5.86%

MomentumView details →

1D Return

−0.34%

YTD Return

−7.59%

1Y Return

+9.44%

RSI (14)

56.3

vs 50D SMA

+3.78%

vs 200D SMA

+4.76%

Capital & dividendView details →

Debt/Equity

0.51x

Current Ratio

1.65x

Quick Ratio

1.25x

Div Yield

0.68%

Div Rate

$1.44

Div Growth 1Y

+18.52%

EarningsView details →

EPS (Actual)

$1.94

EPS Surprise

4.75%

Beats (12Q)

11/12

Next Q EPS Est

$1.91

Avg Surprise (4Q)

6.02%

Rev Surprise

2.31%

Financials snapshotView financials →

Revenue (TTM)

25.11B

Net Income (TTM)

4.00B

Op. CF (TTM)

6.63B

Next earningsOct 20, 2026 →

Latest newsMore news →

NANO Holdings announced that Jack Yamamori, with extensive M&A and management experience in the US, was appointed Vice Chairman in August 2026 to accelerate investment business growth.34d ago

Masimo appointed Tim Benner as president, succeeding Katie Szyman who stepped down in June, following the company's acquisition by Danaher.41d ago

Similar companies

WuXi XDC Cayman Inc02268.HK Thermo Fisher Scientific Inc.TMO Access Bio, Inc.950130.KQ Natera, Inc.NTRA 药明康德603259.SH Agilent Technologies, Inc.A Find similar companies →

Latest newsMore news →

NANO Holdings announced that Jack Yamamori, with extensive M&A and management experience in the US, was appointed Vice Chairman in August 2026 to accelerate investment business growth.34d ago Masimo appointed Tim Benner as president, succeeding Katie Szyman who stepped down in June, following the company's acquisition by Danaher.41d ago